Global Med Technologies(R), Inc. Licenses Its Leading European Blood and Laboratory...

Global Med Technologies(R), Inc. Licenses Its Leading European Blood and
Laboratory Solutions to Homburg, Germany Clinic Blood Center

The University of Saarland Clinic Blood Center Chooses Inlog's EdgeBlood and
EdgeLab to Manage Its Blood Bank and Laboratory

DENVER, April 7 /PRNewswire-FirstCall/ -- Global Med Technologies, Inc.
("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international
healthcare information technology company, today announced that GLI, the
German division of the Company's Inlog subsidiary has licensed its
EdgeBlood(TM) blood information management system and EdgeLab(TM) laboratory
information system to the "Universitatsklinikum des Saarlandes - Institut fur
Klinische Hamostaseologie und Transfusionsmedizin" located in Homburg,
Germany. Terms of the agreement were not disclosed.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)

The University of Saarland Clinic Blood Center collects 30,000 whole blood
donations per year. EdgeBlood and EdgeLab will be deployed on 25 workstations
in the blood center and laboratory. Up to 50 remote users will access the Web
result server EdgeNet. Five analyzers will be connected to EdgeLab, Inlog's
Laboratory Information System.

"After detailed market research, the University Medical Center of Saarland has
decided to install the LIS EdgeBlood/EdgeLab from the company, GLI. This
decision was made because, among other reasons, the system can completely
control the management of all essential services in transfusion medicine.
Moreover, the software is already in use in the National German Red Cross
Blood Donation Services. It has also been used successfully in comparable
university facilities for many years. In view of the connection between
pharmaceutical and clinical aspects of transfusion medicine, EdgeBlood and
EdgeLab will create a center of excellence for the University Medical Center
of Saarland," stated Prof. Dr. med. Hermann Eichler of the Institute of
Clinical Hemostaseology and Transfusion Medicine Homburg/University Medical
Center of Saarland.

EdgeBlood, known as "CTS Serveur" in the French market, is a leading Blood
Center management system that manages all blood that is drawn, tested,
produced and labeled in France by the Etablissement Francais du Sang, the
French Blood Establishment (EFS). EdgeBlood is also used to process more than
half the blood drawn in Germany as well as processing significant parts of the
Austrian and Swiss blood supplies. EdgeBlood is also used in Greece as well
as five African countries. EdgeBlood has an easy-to-use Windows graphical
user interface and contains all major functionality needed by a blood center
from donor recruitment through product distribution.

Since EdgeLab was introduced into the hospital market in 1999 as "Labo
Serveur", it has become a leading Laboratory Information Management System in
Europe with more than 150 licensed laboratories. EdgeLab is connected with
more than 1,000 analyzers and interchanges data with all major hospital
healthcare software packages. It has a vibrant, easy-to-use Windows graphical
interface in addition to a comprehensive range of laboratory functionality.
EdgeLab can be easily configured to meet the business needs of large, diverse,
multi-site hospital laboratories, as well as small, single site hospitals.

Will Willman, Global Med's Sr. Vice President of Sales and Marketing
EU/ME/Asia, commented, "We are pleased to have placed both our EdgeBlood and
EdgeLab solutions at the University of Saarland Homburg Clinic. Our
reputation for having leading edge solutions, as well as excellent service in
Germany, earned this customer for us. We look forward to helping the Homburg
Clinic Blood Center provide quality blood products and services in their
community."

About the University of Saarland Clinic Blood Center
The Universitatsklinikum des Saarlandes has a very large campus comprising 100
buildings, 36 clinics and institutes where almost 5,000 are employed. It was
founded in 1922 and has grown from 1,100 beds to 1,415 and admits 51,051
patients per year.

About Global Med Technologies(R), Inc.
Global Med Technologies, Inc. is an international healthcare information
technology company which develops regulated and non-regulated products and
services for the healthcare industry. As a leading provider of blood and
laboratory systems and services, Global Med's products are deployed in 20
countries and serve over 2,100 transfusion centers, blood banks and laboratory
sites.

Global Med's domestic companies are Wyndgate Technologies(R), a leader in
software products and services for donor centers and hospital transfusion
services; eDonor(R), which offers web-based donor relationship management
systems; and PeopleMed(TM), Inc., which implements cost-effective software
validation, consulting and compliance solutions to hospitals and donor
centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor
center and transfusion management systems as well as cellular therapy
software, laboratory information systems and quality assurance medical
software systems internationally.

For more information about Global Med's products and services, please call
800-996-3428 or visit www.globalmedtech.com.

This news release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made pursuant to the
safe harbor provisions of the Private Securities Litigation Reform Act of
1995. Forward-looking statements inherently involve risks and uncertainties
that could cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions or changes
after the date of this news release.

SOURCE Global Med Technologies, Inc.

Company, Michael I. Ruxin, M.D., +1-303-238-2000, mick@globalmedtech.com, or
Investors, Karen Davis, CFO, +1-916-404-8495, davisk@globalmedtech.com, both
of Global Med Technologies, Inc.